Dr Giovanni Fava shares his perspective on the current intellectual crisis in psychiatry and how it stems from a narrow concept of science which neglects clinical practice as a source of fundamental research questions.
Awais Aftab, MD
How have the pharmaceutical industry and academic guild interests shaped the evolution of psychiatry? Lisa Cosgrove, PhD, has something to say about it.
"The idea of seeing a patient, not just a diagnostic label, is an extremely valuable lesson. Being primed to see certain behaviors as pathological in certain contexts and perfectly normal in others is something that all doctors should be aware of." -Susannah Cahalan
To read Linehan’s memoir is to realize that she underwent a crucifixion and resurrection of her own, and that the Pontius Pilate in her story is psychiatry itself.
A Conversation in Critical Psychiatry with Peter J. Whitehouse, MD, PhD.
The author shares some thoughts on the current state of biopsychosocial model as well as the new proposed reinterpretation of BPS as a theory of causality.
This CME activity provides an understanding of treatment resistant depression (TRD) in elderly patients.
Since a disappointingly large number of people equate the critical psychiatry movement with the antipsychiatry movement, two psychiatrists shed light on why that is not the case.
"Psychiatry has been frozen in time since the 80s, and hence the absence of progress since then is no surprise." So says, S. Nassir Ghaemi, MD, MPH, in the next installment of Conversations in Critical Psychiatry with Awais Aftab, MD.
"Go out into the real world; work in prisons, in run-down towns with high unemployment or with refugees or in remote areas. Go overseas or into underprivileged parts of your own country. And that is how you learn about real psychiatry," says Niall McLaren, MBBS, FRANZCP, in the next installment of Conversations in Critical Psychiatry.